![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 23, 20833-20839, June 7, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, November 21, 2001, and in revised form, March 18, 2002
Site-directed Mutagenesis--
Site-directed mutagenesis was
performed using the PCR method. Construction of the mutants was
done using plasmid pEGT-d129 as the template; this contains a
BamHI/EcoRI fragment inserted into pET23a vector,
coding for residues 130-402 of bovine Gal-T1 (11), and has a Cys-342
to Thr mutation.
The mutation primers corresponding to the upper DNA strand are: Y289L,
5'-CCTTACGTGCAATTGTTTGGAGGTGTCTCTGCTCTAAGTAAA-3' and 5'-GACACCTCCAAACAATTGCACGTAAGGTAGGCTAAA-3'; Y289I, 5'-CTACCTTACGTGCAGATCTTTGGAGGTGTCTCTGCTCTAAG-3'
and
5'-GACACCTCCAAAGATCTGCACGTAAGGTAGGCTAATCCAA-3'; Y286N,
5'-GGATTAGCCTACCATATGTGCAGAATTTTGGAGGTGTCTCT-3' and
5'-AGAGACACCTCCAAAATTCTGCACATATGGTAGGCTAAATCC-3'.
The restriction sites are shown in italics and the mutation codon in bold letters. Typically, the entire Gal-T1 DNA was PCR-amplified as
two fragments using the terminal cloning primers and two mutagenesis primers. The fragments were then cut with the restriction enzymes MfeI, BglII, and NdeI for Y286L,
Y286I, and Y286N mutants, respectively, and ligated. The full Gal-T1
DNA with the mutation was amplified from the ligation mixture using the
cloning primers and then inserted into the pET23a vector. Mutants were
screened for the incorporated mutations, based on alterations in the
restriction enzyme digestion patterns, and then sequenced. The positive
clones were transformed into B834(DE3)pLysS cells as described
previously (7). The mutant proteins were expressed and purified
according to the published method (7).
Gal-T and GalNAc-T Enzyme Assays--
The protein concentrations
were measured using the Bio-Rad protein assay kit, based on the method
of Bradford and further verified on SDS gel. An in vitro
assay procedure for Gal-T1 has been reported previously (7). The
activities were measured using UDP-Gal or UDP-GalNAc as sugar
nucleotide donors, and GlcNAc and Glc as the acceptor sugars. For the
specific activity measurements, a 100-µl incubation mixture
containing 50 mM Studies for Determining the Kinetic Constants--
The true
Km of the donor (KA) and of
the acceptor (KB), the dissociation constant of
the donor, Ki(a), and
kcat, were obtained using two-substrate analyses
and the primary plots of five concentrations of donor (UDP-Gal or
UDP-GalNAc) and five concentrations of acceptor, and the corresponding
secondary plots of the intercepts and slopes. Initial rate conditions
were linear with respect to time. A suitable range of donor and
acceptor concentrations were chosen, which allowed an accurate
Michaelis-Menten plot to be derived. The data were also analyzed for a
general two-substrate system using the following equations (12) with the software EnzFitter, a Biosoft nonlinear curve-fitting program for Windows.
1H NMR Spectroscopy of the Product of GalNAc-T
Activity--
The reaction was carried out in a total volume of 1 ml
that contained 100 µg of Y289L mutant plus 10 mM each
triethanolamine-HCl, pH 8.0, UDP-GalNAc, GlcNAc, and MnCl2
at 37 °C for 48 h. The mixture was first passed through a 1-ml
Chelex 100 column and then through a 1-ml cationic column containing
AG1-X8 resin (200-400-mesh). The disaccharide product in the
flow-through from 4 bed volumes was pooled and freeze-dried. The
product was finally dissolved in 400 µl of D2O, and its
1H NMR spectrum was obtained in a 400-MHz NMR spectrometer.
Crystal Structure Determination--
The catalytic domain of the
recombinant bovine Gal-T1 from residues 130 to 402 (mass ~33 kDa) and
mouse recombinant LA (mass ~14 kDa) was co-crystallized in the
presence of UDP-GalNAc and MnCl2. The crystals were grown
at room temperature by the hanging drop method, using 20 mg
ml
The crystal structures were solved by the molecular replacement method,
using AMORE (14). The crystal structure of lactose synthase (9) without
the substrate was used as the model for molecular replacement. After
initial refinement, the difference electron density maps revealed the
UDP-GalNAc and a Mn2+ ion bound to the Gal-T1 molecule and
were included for further refinement. The two LS molecules in the
asymmetric unit are related by a pseudo 2-fold symmetry. All the
refinements were carried out initially by XPLOR3.85, followed by CNS1.0
(15). Only reflections with F > 2 Crystal Structure of Gal-T1·LA·UDP-GalNAc Complex and Molecular
Interactions of UDP-GalNAc Molecule--
The overall molecular
structure and the interactions between Gal-T1 and LA molecules in the
Gal-T1·LA·UDP-GalNAc·Mn2+ are quite similar to those
observed in the previous crystal structure of Gal-T1·LA·UDP·
Mn2+ complex (10). The mean r.m.s. deviation on C
Although the interactions of Gal-T1 with the GalNAc moiety of
UDP-GalNAc are similar to the interactions of the Gal moiety of UDP-Gal
(17), additional interactions are observed between the
N-acetyl group of UDP-GalNAc with Gal-T1 (Fig.
1B). In the Gal-T1·UDP-Gal complex, the O2 hydroxyl group
forms only one hydrogen bond with Asp-252, but in the present crystal
structure the N2 nitrogen atom is hydrogen-bonded to the Asp-252 side
chain carboxylate oxygen atom, whereas the carbonyl oxygen atom is
hydrogen-bonded to the Tyr-289 side chain hydroxyl group. The presence
of the N-acetyl group seems to have perturbed the
conformation of both the GalNAc and the Tyr-286 side chain. The
orientation of the N-acetyl group with respect to the sugar
ring is represented by the torsion angle H2-C2-N2-HN, which in the case
of GalNAc, GlcNAc, and ManNAc was observed to be nearly 180 ° (18).
In the present crystal structure, there are two
Gal-T1·LA·UDP-GalNAc·Mn2+ molecules in the asymmetric
unit; in one molecule the torsion angle is 150° and in the other it
is 120°, suggesting the existence of the N-acetyl group in
an unfavorable orientation. This unfavorable orientation is a result of
the lack of space between the side chain hydroxyl group of Tyr-289 and
the carbonyl oxygen atom of the N-acetyl group. In the two
molecules of the asymmetric unit, because of this slight difference in
the torsion angle of H2-C2-N2-HN, orientation of the side chain of
Tyr-289 is slightly different to accommodate the N-acetyl group.
Effect of the N-Acetyl Group of GalNAc on GalNAc-T
Activity--
Among the interactions of the N-acetyl
group of UDP-GalNAc with the Gal-T1 molecule, the hydrogen bond between
the carbonyl oxygen atom of the N-acetyl group and the
Tyr-289 side chain hydroxyl group seems to cause steric hindrance for
catalysis. Studies using positional isotope exchange, secondary
deuterium isotope effects, and inhibition of catalytic activity by
acceptor analogs have suggested a plausible catalytic mechanism for the
Gal-T1 (19-21). According to this mechanism, upon a nucleophilic
attack from the O4 hydroxyl group of the acceptor molecule, Gal moiety,
during its separation from UDP-Gal in the transition state complex,
exits with a substantial sp2 character at the anomeric
center C1. Such an oxocarbonium ion intermediate forms a covalent
linkage with the O4 oxygen atom, forming a Comparison of Gal-T and GalNAc-T Catalytic Activities of Wild-type
and Gal-T1 Mutants--
The mutants Y289L, Y289N, and Y289I exhibit
both Gal-T and GalNAc-T activities at the saturation substrate
concentrations (Table II and Fig.
3). The mutants Y289L and Y289N exhibit
equally strong Gal-T and GalNAc-T activities, suggesting that a Leu or Asn substitution of Tyr-289 seems to create the required optimal space.
The specific GalNAc-T activity of the mutant Y289I at the saturation
concentration is half that of Y289L (Table II); it exhibits a slightly
weaker affinity to UDP-GalNAc (Fig. 3). Therefore, an Ile substitution
seems to create more than the required space, thus reducing the
specific activities. Although Asn substitution exhibits the GalNAc-T
activity as well as the Leu substitution, the protein seems to be less
stable and tends to denature rapidly compared with the Leu mutant. It
has been shown that wt-Gal-T1 exhibits a very low glucosyltransferase
activity (Glc-T), but no N-acetylglucosaminyltransferase
(GlcNAc-T) activity (3, 6, 7). On the contrary, the mutants exhibit
reasonable GlcNAc-T activity (Table II) where they transfer GlcNAc from
UDP-GlcNAc to the acceptor GlcNAc but do not exhibit Glc-T activity. It
is interesting to note that in this GlcNAc-T activity the initial product, the disaccharide GlcNAc
Because the Y289L variant of Gal-T1 exhibits both Gal-T and GalNAc-T
enzyme activities with equal efficiencies, double substrate kinetic
studies were carried out to determine the kinetic constants for both
the donor and acceptor molecules. The kinetic data from both reactions
fit best to Equation 2, with a zero
Ki(a) value, describing an asymmetric
initial velocity pattern for a double-displacement or "ping-pong"
mechanism. The Y289L mutant in the Gal-T reaction shows for the
acceptor nearly 20-fold higher Km than the wild-type
Gal-T1 (Table III). The catalytic constant (kcat) in the Gal-T1 reaction is
comparable with the wild type, but it is nearly 3-5-fold higher in the
GalNAc-T reaction (Table III). It is possible that this high
kcat was achieved either by stabilizing the
transition state or by the increase in the free energy of the ternary
complex. Although the mutation was designed to eliminate the steric
hindrance caused by Tyr-289 during the transition state, the latter
possibility cannot be ruled out because of the observed high
Km value for the acceptor GlcNAc. In the crystal
structure of Gal-T1, the residues around Tyr-289 are involved in the
acceptor binding. The lack of an aromatic side chain at position 289 may destabilize these residues, thus affecting the binding of the
acceptor substrate. This is substantiated by the earlier mutational
studies on human Gal-T1, where substitution by Phe for the
corresponding residue Tyr-287 does not affect the acceptor binding,
whereas substitution with Gly totally abolished the catalytic activity
(22). Currently, mutational studies are being carried out to enhance
the acceptor affinity of Y289L mutant to determine which mechanism is
responsible for the high catalytic efficiency of the enzyme.
Although the weak GalNAc-T activity of the wild-type Gal-T1 had been
demonstrated in the earlier studies and the product disaccharide, di-N-acetyllactosediamine (LacdiNAc), was characterized by
1H NMR technique, no details were reported (6). Because the Y289L mutant exhibits equally high GalNAc-T activity as it does Gal-T
activity, the disaccharide product from this reaction was purified and
analyzed by 1H NMR spectroscopy (Fig.
4). Previously, the same product
LacdiNAc, from a N-acetylgalactosaminyltransferase isolated
from bovine mammary gland, had been fully characterized by
1H NMR spectroscopy (23). The present NMR spectrum is quite
similar to that of the already characterized LacdiNAc, demonstrating
that the mutant Y289L transfers GalNAc from UDP-GalNAc to GlcNAc,
forming a A Point Mutation in the Codon for Amino Acid 289 Can Convert the
Enzyme with Dual Property--
In humans, the Role of LA in the GalNAc-T Activity of the wt-Gal-T1 and the Y289L
Mutant--
Although Gal-T1 transfers GalNAc from UDP-GalNAc to GlcNAc
with ~0.1% of its Gal-T efficiency, it has been shown that LA
enhances this transfer (5), a situation similar to glucosyltransferase activity (Glc-T) of Gal-T1, where LA increases this activity from 0.3 to 10% (7). We have shown previously through crystal structure and
enzyme kinetic studies that, in the Glc-T reaction, LA plays a kinetics
role in stimulating Gal-T1 to transfer Glc from the UDP-Glc to GlcNAc
(7, 9). Although we have not carried out detailed kinetic studies on
the GalNAc-T reaction by the wild-type Gal-T1 in the presence of LA,
the similarity between Glc-T and GalNAc-T catalytic activities
indicates that LA probably plays a similar role in the GalNAc-T
reaction. It has been stated that LA enhances this GalNAc-T activity to
55% of its Gal-T activity (5); however, we find that the activity is
enhanced only to nearly 1% (data not shown). This may have been
because of the differences in the assay methods. For example, in the
present study and the studies reported by others (12), the donor
concentration is determined by the unlabeled UDP-sugar, and only a
small amount of 3H-labeled UDP-sugar is used during the
assay. Therefore, the catalytic activity is determined accurately by
the amount of unlabeled UDP-sugar used, whereas, in the previous study
(5), the specific activity of the 3H-labeled UDP-GalNAc
provided by the manufacturer was used to determine the specific
activity of the enzyme.
Unlike wt-Gal-T1, where LA stimulates the transfer of GalNAc only to
GlcNAc and not to Glc (5), the Tyr-289 mutants (Y289L, Y289N, and
Y289I) in the presence of LA transfer GalNAc preferably to Glc rather
than to GlcNAc. This property is quite similar to LS activity in which
the wt-Gal-T1 in the presence of LA transfers Gal to Glc instead to
GlcNAc (Table V). Furthermore, like
wt-Gal-T1, these mutants also transfer Gal to Glc in the presence of LA
(data not shown). For example, an
N-acetylgalactosaminyltransferase activity in the bovine
mammary gland extracts with a similar catalytic property has been
identified (26). This enzyme also transfers GalNAc from UDP-GalNAc to
GlcNAc in the absence of LA, whereas in the presence of LA it transfers
GalNAc to Glc instead to GlcNAc. In fact, a small amount of the lactose
analogue GalNAc Conclusion--
The crystal structure of UDP-GalNAc bound to
Gal-T1 shows that the carbonyl oxygen atom of the N-acetyl
group of GalNAc is hydrogen-bonded to the hydroxyl group of Tyr-289,
which hinders the transfer of GalNAc during catalysis. For the Gal-T1
to function efficiently as GalNAc-T, an optimal space for the binding
of the N-acetyl group of UDP-GalNAc to Gal-T1 is required,
and such a space need not be hydrophobic nor hydrophilic in nature. In
the present study, we have shown that the Tyr-289 mutants of Gal-T1, which have an optimal space for the binding of N-acetyl
group, exhibit as high GalNAc-T activity as Gal-T activity, as well as GlcNAc-T activity. In the human Gal-T family members, the Tyr/Phe residue at 287 (or in bovine Tyr-289) seems to be important for determining the donor sugar specificity of these enzymes, and mutation
of this residue broadens the donor specificity of the enzyme. The
present study suggests that a single point mutation can result in
glycan moieties substituting Gal with GalNAc or GlcNAc, which may have
significant effects on cellular functions.
We thank Dr. Zbgniew Dauter for help with
synchrotron data collection. We thank Dr. Soma Kumar for helpful
discussions and comments during preparation of the manuscript. All the
NMR spectra were recorded in the Analytical Chemistry Laboratory,
NCI-Frederick (Frederick, MD). The primers were synthesized by the
Molecular Technology Laboratory, NCI-Frederick.
*
This work was supported by federal funds from the NCI,
National Institutes of Health, under Contract NO1-CO-12400.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The atomic coordinates and the structure factors (code 1L7W) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
¶
To whom correspondence should be addressed: Structural
Glycobiology Section, LECB, CCR, NCI-Frederick, Bldg. 469, Rm. 221, Frederick, MD 21702. Tel.: 301-846-1934; Fax: 301-846-7149;
E-mail: qasba@helix.nih.gov.
Published, JBC Papers in Press, March 26, 2002, DOI 10.1074/jbc.M111183200
The abbreviations used are:
Structure-based Design of
1,4-Galactosyltransferase I
(
4Gal-T1) with Equally Efficient
N-Acetylgalactosaminyltransferase Activity
POINT MUTATION BROADENS
4Gal-T1 DONOR SPECIFICITY*
§ and
¶
Structural Glycobiology Section and
§ Intramural Research Support Program-SAIC, Laboratory
of Experimental and Computational Biology, Center for Cancer Research,
NCI-Frederick, National Institutes of Health,
Frederick, Maryland 21702
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
1,4-Galactosyltransferase I (Gal-T1) normally
transfers Gal from UDP-Gal to GlcNAc in the presence of
Mn2+ ion. In the presence of
-lactalbumin (LA),
the Gal acceptor specificity is altered from GlcNAc to Glc. Gal-T1 also
transfers GalNAc from UDP-GalNAc to GlcNAc, but with only ~0.1% of
Gal-T activity. To understand this low GalNAc-transferase activity, we
have carried out the crystal structure analysis of the Gal-T1·LA complex with UDP-GalNAc at 2.1-Å resolution. The crystal structure reveals that the UDP-GalNAc binding to Gal-T1 is similar to the binding
of UDP-Gal to Gal-T1, except for an additional hydrogen bond formed
between the N-acetyl group of GalNAc moiety with the Tyr-289 side chain hydroxyl group. Elimination of this additional hydrogen bond by mutating Tyr-289 residue to Leu, Ile, or Asn enhances
the GalNAc-transferase activity. Although all three mutants exhibit
enhanced GalNAc-transferase activity, the mutant Y289L exhibits
GalNAc-transferase activity that is nearly 100% of its Gal-T activity,
even while completely retaining its Gal-T activity. The steady state
kinetic analyses on the Leu-289 mutant indicate that the
Km for GlcNAc has increased compared to the wild
type. On the other hand, the catalytic constant
(kcat) in the Gal-T reaction is comparable with
the wild type, whereas it is 3-5-fold higher in the GalNAc-T
reaction. Interestingly, in the presence of LA, these mutants also
transfer GalNAc to Glc instead of to GlcNAc. The present study
demonstrates that, in the Gal-T family, the Tyr-289/Phe-289 residue
largely determines the sugar donor specificity.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
1,4-Galactosyltransferase I
(
4Gal-T1,1 EC 2.4.1.38)
catalyzes the transfer of galactose (Gal) from UDP-Gal to the
N-acetylglucosamine (GlcNAc) residue present at the
nonreducing terminal end of glycans of glycoproteins and glycolipids
(1), producing
1,4-linked galactosylated glycan. In addition to
GlcNAc as an acceptor, the enzyme can also use other sugars, such
as N-acyl-substituted glucosamines and
N-acetyl-D-mannosamine, as acceptors (2). The
enzyme does not have an absolute requirement for the sugar donor
UDP-Gal; instead, it exhibits polymorphic donor specificity, in that it also transfers glucose (Glc), D-deoxy-Glc, arabinose,
GalNAc, and GlcNAc from their UDP derivatives, albeit at low rates
(0.3-5%) compared with Gal transfer (3-7).
-Lactalbumin (LA), a mammary gland-specific calcium-binding
protein, alters the sugar acceptor specificity of Gal-T1 toward Glc
(8). This activity is described as the lactose synthase (LS) activity
of
4Gal-T1 (EC 2.4.1.22). LA has been shown to alter not only the
sugar acceptor specificity of the enzyme, but also its sugar donor
specificity (7, 9), because it stimulates the transfer of Glc from
UDP-Glc to GlcNAc. Similarly, it has been shown previously that the
transfer of GalNAc from UDP-GalNAc to GlcNAc by Gal-T1 is also enhanced
in the presence of LA (5). To better understand the modulation of
substrate specificity, we had carried out a series of studies on the
crystal structure of LA·Gal-T1 complex with various substrates (7,
10). Analysis of the molecular interactions between LA·Gal-T1 and Glc
from the crystal structure suggested an explanation for the way in
which LA modulates the acceptor specificity (10). The structural
studies of the LA·Gal-T1 complex with UDP-Glc, together with the
kinetic studies of Glc transfer from UDP-Glc to an acceptor sugar, also offered an explanation for the way in which LA modulates the donor specificity of Gal-T1 (7). In our continuing efforts to understand the
structure and function of Gal-T1, we examined in the present study the
interaction of UDP-GalNAc with Gal-T1. The results suggest that the
formation of a hydrogen bond between GalNAc and Tyr-289 is responsible
for the poor GalNAc-transferase activity that Gal-T1 exhibits. On the
other hand, mutation of Tyr-289 to leucine, isoleucine, or asparagine
enhances the GalNAc-transferase activity. Among these mutants, Y289L
has GalNAc-transferase activity that is nearly equal to Gal-T activity.
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
-benzyl-GlcNAc, 10 mM
MnCl2, 10 mM Tris-HCl, pH 8.0, 500 µM UDP-Gal or UDP-GalNAc, 20 ng of Gal-T1, and 0.5 µCi
of [3H]UDP-Gal or [3H]UDP-GalNAc was used
for each Gal-T or GalNAc-T reaction. The incubation was carried out at
37 °C for 10 min. The reaction was terminated by adding 200 µl of
cold 50 mM EDTA, and the mixture was passed through a
0.5-ml bed volume column of AG1-X8 cation resin (Bio-Rad) to remove any
unreacted [3H]UDP-Gal or [3H]UDP-GalNAc.
The column was washed successively with 300, 400, and 500 µl of
water, and the column flow-through was diluted with Biosafe
scintillation fluid; radioactivity was measured with a Beckman counter.
A reaction without the acceptor sugar was used as a control. A similar
assay was carried out to measure the GalNAc-T activity with Glc and
other acceptors in the presence of 50 µM bovine LA (Sigma).
(Eq. 1)
Here
(Eq. 2)
is the initial velocity and the rate equation for
sequential symmetrical initial velocity pattern associated with Equation 1, an ordered or random equilibrium mechanism in which substrate A dissociates well from the E·S
complex with a dissociation constant of
Ki(a). Equation 2 is for asymmetric initial velocity pattern for a double-displacement or "ping-pong" mechanism. The kinetic parameters KA,
KB, Ki(a), and
Vmax, were obtained from the fitted curves using
the above rate equations. The graphical method and EnzFitter program
gave very similar kinetic parameters. In the GalNAc-T assay, the
maximum substrate concentrations used for UDP-GalNAc and GlcNAc were 1 and 200 mM, respectively. However, in the Gal-T assay,
because of the limited solubility of GlcNAc in water, the concentration of GlcNAc was limited to no more than 400 mM (which is
2-fold higher than its Km value), whereas up to 300 µM UDP-Gal were used.
1 Gal-T1 and 10 mg ml
1 LA in the presence
of a substrate with the precipitant containing 100 mM NaCl,
100 mM sodium citrate buffer, pH 5.6, and 12.5%
polyethylene glycol 4000. The crystals of the complex could only be
obtained in the presence of 17 mM UDP-GalNAc and
MnCl2. Complete three-dimensional x-ray diffraction data
were collected at beam line X9B, National Synchroton light source,
Brookhaven National Laboratory, using a Quantum-4 ccd detector
with 1.02-Å wavelength. The frames were processed using DENZO (13).
The crystals belong to monoclinic, space group P21 with the
cell constants a = 57.5, b = 95.7, c = 100.6 Å, and
= 101.4°. A total of
120,498 reflections were collected, of which 62,285 are unique (90%
completeness), with an Rsym of 6.0%.
(F)
were used for the refinement. The final R factor for the
55,765 reflections is 23.2% with Rfree (10%
reflections) is 27%. The mean r.m.s. deviations of the bond lengths
and angles are 0.001 Å and 0.01°, respectively. All the figures were
drawn using MOLSCRIPT (16).
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
atoms
between these two structures is only 0.7 Å (Fig.
1A), indicating that binding
of UDP-GalNAc has neither perturbed the crystal structure of Gal-T1 nor
its interactions with LA. In the crystal structure the UDP-GalNAc
molecule and a Mn2+ ion could be clearly located from the
electron density maps. The Mn2+ ion exhibits six
coordinations: two with UDP-GalNAc, three with Gal-T1, and one with a
water molecule (Table I). Although these coordinations are quite similar to those found in the previous crystal
structure of the Gal-T1·LA·sugar nucleotide·metal complexes (7,
10), the sixth coordination with a water molecule has not been
observed. Even though there is enough space available for this water
molecule to coordinate with the Mn2+ ion in the previous
crystal structures, none was observed (7, 10, 17). This may be because
of the presence of the bulky N-acetyl group in UDP-GalNAc,
which may better trap the water molecule.

View larger version (35K):
[in a new window]
Fig. 1.
A, superposition of the C atoms of the
protein complex Gal-T1·LA·UDP-GalNAc·Mn2+
(red) with the Gal-T1·LA·UDP·Mn2+ complex
(blue). The Mn2+ ion is shown as a
blue sphere and UDP-GalNAc in
ball-and-stick. The mean r.m.s. deviation between these two
structures is only 0.7 Å, indicating that the overall structure of
Gal-T1 and its interactions with LA have not been perturbed by the
binding of UDP-GalNAc. The Protein Data Bank identification code for
the coordinates of Gal-T1·LA·UDP-GalNAc·Mn2+ complex
is 1L7W. B, molecular interactions between the GalNAc moiety
of UDP-GalNAc and Gal-T1 molecule. The Mn2+ ion forms six
coordinations; five are similar to the coordinations found in the
crystal structure of Gal-T1·UDP-Gal·Mn2+ complex (17).
The additional sixth coordination with a water molecule is only
observed in the present crystal structure. Although the hydrogen
bonding interactions observed are similar to that of Gal moiety with
Gal-T1 in the Gal-T1·UDP-Gal complex, an additional hydrogen bond is
observed between the carbonyl oxygen atom of the N-acetyl
group of UDP-GalNAc and the side chain hydroxyl group of Tyr-289. This
hydrogen bond seems to be hindering the GalNAc-transferase activity
(see Fig. 2B). Additionally, the N-acetyl group
seems to be in a less favorable orientation; the torsion angle
H2-C2-N-HN being 120°, instead of 180° as is observed normally. All
the hydrogen bonds are shown by dashed
lines.
Mn2+ ion coordination distances in the crystal structure of
Gal-T1·LA·UDP-GalNAc·Mn2+
).
1-4 glycosidic linkage
between galactose and the acceptor molecule. Because it is not feasible
to obtain the crystal structure of Gal-T1 in the presence of both donor
and acceptor molecules to determine the nature of interactions between
the substrates and Gal-T1, we have carried out modeling studies based
on the individual donor and acceptor bound to Gal-T1 structures (10, 17). These studies indicated that the O4 hydroxyl group of the acceptor
lines up against the anomeric center C1 of the bound UDP-Gal molecule
at 4.5 Å (Fig. 2A). During
catalysis, this assembly of the substrates in the catalytic pocket
requires the displacement of the substrates toward each other. Because
any displacement of the acceptor GlcNAc toward the donor is prevented
by Trp-314, it is most likely that the donor Gal moiety moves toward
the acceptor during catalysis. In the Gal-T reaction, when the Gal
moiety is involved during catalysis, there is enough space between the
C2 atom of Gal and the side chain of Tyr-289, as the O2 hydroxyl group
of Gal is facing away from the Tyr-289 residue (Fig. 2A). However, in the crystal structure of
Gal-T1·LA·UDP-GalNAc·Mn2+, the bulky
N-acetyl group of GalNAc occupies this space with its
carbonyl oxygen atom hydrogen-bonded to the hydroxyl group of Tyr-289
(Fig. 2B). We hypothesized from this observation that, during catalysis, this hydrogen bond is expected to hinder the reaction
by not allowing the GalNAc moiety to move toward the acceptor molecule.
Second, because of lack of available space between the
N-acetyl group and Tyr-289, the former exists in a less
favorable orientation. To create the space in the Gal-T1 molecule in
the vicinity of the N-acetyl group binding site of UDP-GalNAc, we mutated the Tyr-289 residue to Leu, Ile, or Asn (Fig.
2C). A phenylalanine mutation was not considered, because it
does not create enough space when the N-acetyl group adopts its favorable conformation. Although Leu or Asn residue substitution creates a similar pocket because of the similarity of their side chain
length (Fig. 2C), Leu is expected to create a hydrophobic pocket whereas Asn creates a hydrophilic one. Additionally, because of
its shorter side chain length, an Ile substitution would be expected to
create even a larger pocket size than the Leu substitution. Thus,
investigations of these three mutants were expected to identify the
required size and the nature of the pocket in the vicinity of the
N-acetyl group-binding site of UDP-GalNAc.

View larger version (28K):
[in a new window]
Fig. 2.
A, modeling of the
GlcNAc in its binding site (based on the crystal structure of
Gal-T1·LA·GlcNAc complex) on the Gal-T·UDP-Gal·Mn2+
crystal structure (17). As can be seen, the acceptor atom O4 of GlcNAc
is in the proper orientation with the anomeric center (C1 atom) of the
Gal moiety of UDP-Gal. The distance between these atoms is ~4 Å. It
has been hypothesized that the enzyme catalysis follows the separation
principle, in which the Gal moiety is expected to move toward the
acceptor while forming the disaccharide. Because there is enough space
between Tyr-289 and the Gal moiety, Tyr-289 is not expected to hinder
the Gal-T activity. This is illustrated by the dotted
surface showing the van der Waals sphere for the Tyr-289
side chain hydroxyl group and the C2 and O2 atoms of the Gal moiety.
B, modeling of the GlcNAc in its binding site on the
Gal-T1·LA·UDP-GalNAc·Mn2+ crystal structure. Because
LA does not interact with the donor molecule, it is not shown in the
figure. Similar to UDP-Gal binding (Fig. 2A), the O4 atom of
GlcNAc is located ~4 Å away from the anomeric center of GalNAc
moiety of UDP-GalNAc. The major difference between the binding of
UDP-Gal and UDP-GalNAc seems to be an additional hydrogen bond observed
between the N-acetyl group and Gal-T1, particularly with
Tyr-289. The side chain hydroxyl group of Tyr-289 is hydrogen-bonded
with the carbonyl oxygen atom of the N-acetyl group of
GalNAc (shown by double arrow). If the catalytic
mechanism still follows the separation principle, this hydrogen bond
would hinder the required displacement of the GalNAc moiety during the
disaccharide linkage formation. As can be seen from the van der Waals
sphere (dotted surface), little space exists
between the Tyr side chain hydroxyl group and the N-acetyl
group. Therefore, based on this observation, it was hypothesized that
lack of space is responsible for the poor GalNAc-T activity.
C, based on the hypothesis that more space is needed between
the N-acetyl group of UDP-GalNAc and Tyr-289 residue to
facilitate the reaction, the substitution of Tyr-289 by Leu is modeled.
The van der Waals sphere shown in dotted surface
for the side chain atoms of Leu-289 and the N-acetyl group
clearly indicates that such substitution creates additional
space.
1,4-GlcNAc, itself is an acceptor for the enzyme, thus producing tri- and longer chain saccharides. A
separate study on this GlcNAc-T property is being carried out.
Specific activities of the catalytic domain of Gal-T1 (d129-Gal-T1,
residues 130-402) with C342T mutation and the Tyr-289 mutants
-benzyl-GlcNAc was at 25 mM. In the
Gal-T reaction of C342T, the acceptor concentration was 10 mM, because at 25 mM it showed inhibition.
Because Y289N rapidly undergoes denaturization, reliable data could not
be obtained.

View larger version (13K):
[in a new window]
Fig. 3.
The catalytic activity of the wt-Gal-T1 and
the mutantsY289L, Y289I, and Y289N. A, Gal-T activity
of wt-Gal-T1 and of mutants at the saturating concentrations of
-benzyl-GlcNAc as the acceptor (see "Materials and Methods").
The mutant Y289L seems to be as active as the wt-Gal-T1, whereas Y289I
seems to be weaker. B, GalNAc-T activity of the wt-Gal-T1
and of mutants. The wt-Gal-T1 exhibits very poor GalNAc-T activity,
whereas Y289L exhibits more GalNAc-T activity than its Gal-T activity.
Y289I exhibits a somewhat weaker GalNAc-T activity, compared with that
of Y289L. The activities are measured with 50 mM
-benzyl-GlcNAc as acceptors at different concentrations of the
donor. The Gal-T activity of the wt-Gal-T1 was measured with only 10 mM
-benzyl-GlcNAc, because it showed inhibitions at 50 mM concentration.
Kinetic parameters for the donor and the acceptor substrates by
Y289L_C342T mutant in the Gal-T and GalNAc-T catalytic reactions
(see text for assay conditions)
1-4 linkage between GalNAc and GlcNAc.

View larger version (21K):
[in a new window]
Fig. 4.
Partial 1H NMR spectrum of the
disaccharide (LacdiNAc) product from the GalNAc-T reaction with GlcNAc
as the acceptor. The NMR spectrum is quite similar to that of the
LacdiNAc product obtained using bovine mammary gland
1,4-N-acetylgalactosaminyltransferase (25). The
signal for the GalNAc anomeric proton is at
4.53 ppm and for the
GlcNAc anomeric proton corresponding to an
and a
conformer is
at
5.2 and 4.7 ppm. The signals from the acetyl group of each sugar
moiety are at
2.05 and 2.08 ppm.
4Gal-T family has
seven members (Gal-T1 to -T7), each with high sequence identity within
their catalytic domain (24, 25). These family members are known to
transfer Gal from UDP-Gal to different sugar acceptors. For example,
Gal-T6 transfers Gal to Glc of Glc-ceramide, whereas Gal-T7 transfers
Gal to xylose (25). Among these seven members, four members, Gal-T1 to
Gal-T4, have a Tyr residue at position 287 (which corresponds to
Tyr-289 in bovine Gal-T1), whereas Gal-T5 and Gal-T6 have a Phe
residue. Mutational studies in human Gal-T1 have shown that theY287F
mutant exhibits the same enzyme characteristics with kinetic constants as that of the wild-type Gal-T1 (22). Because the Phe residue may also
create a similar steric problem for UDP-GalNAc as the Tyr residue,
these enzymes are expected to exhibit low GalNAc-T activity. It is
interesting to note that the family members show variation in their
codon nucleotide sequence for residue 287 (Table IV), particularly at the second and third
nucleotide positions of the codon. A mutation of the first nucleotide
base thymidine (T) to either adenine (A) or cytidine (C) would result
in a mutation of the Tyr/Phe residue to either Leu or Asn. Such a
spontaneous point mutation at the first nucleotide position of the
codon for the residue 287 would generate an enhanced equal
GalNAc-transferase activity that might have adverse effects.
Incorporation of GalNAc instead of Gal might lead to 1) termination of
the total synthesis of a glycoconjugate, or 2) glycans with different
oligosaccharide sequence. It is worth noting, however, that, although
mutants may possess dual enzyme activities, the substitution of Gal by GalNAc is expected to be highly irregular and will depend on whether or
not UDP-GalNAc is available in the Golgi apparatus.
Codon usage for the amino acid at position 289 among the Gal-T1
family members
1-4Glc is found in the milk (26). However, the
protein sequence for this N-acetylgalactosaminyltransferase
is not yet known. Thus, it seems that an
N-acetylgalactosaminyltransferase enzyme is present in cells
with enzyme properties similar to the present mutants. The exact nature
and the function of the oligosaccharide synthesized involving this
enzyme are not yet known. It has been pointed out that, in Madin-Darby
canine kidney cells, large amounts of N-glycans are found to
carry GalNAc instead of Gal, linked
1,4 to GlcNAc (27).
GalNAc-T catalytic activity of Y289L mutant in the absence and the
presence of LA on various acceptor substrates
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
![]()
ABBREVIATIONS
4Gal-T1,
1,4-galactosyltransferase I;
LA,
-lactalbumin;
LS, lactose
synthase;
wt, wild-type;
r.m.s., root mean square;
LacdiNAc, di-N-acetyllactosediamine;
GalNAc-T, N-
acetylgalactosyltransferase.
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
1.
Hill, R.
(1979)
UCLA Forum Med. Sci.
21,
63-86[Medline]
[Order article via Infotrieve]
2.
Berliner, L. J.,
Davis, M. E.,
Ebner, K. E.,
Beyer, T. A.,
and Bell, J. E.
(1984)
Mol. Cell. Biochem.
62,
37-42[CrossRef][Medline]
[Order article via Infotrieve]
3.
Berliner, L. J.,
and Robinson, R. D.
(1982)
Biochemistry
21,
6340-6343[CrossRef][Medline]
[Order article via Infotrieve]
4.
Andree, P. J.,
and Berliner, L. J.
(1978)
Biochim. Biophys. Acta
544,
489-495[Medline]
[Order article via Infotrieve]
5.
Do, K. Y., Do, S. I.,
and Cummings, R. D.
(1995)
J. Biol. Chem.
270,
18447-18451 6.
Palcic, M. M.,
and Hindsgaul, O.
(1991)
Glycobiology
1,
205-209 7.
Ramakrishnan, B.,
Shah, P. S.,
and Qasba, P. K.
(2001)
J. Biol. Chem.
276,
37665-37671 8.
Qasba, P. K.,
and Kumar, S.
(1997)
Crit. Rev. Biochem. Mol. Biol.
32,
255-306[Medline]
[Order article via Infotrieve]
9.
Ramakrishnan, B.,
Boeggeman, E.,
and Qasba, P. K.
(2002)
Biochem. Biophys. Res. Commun.
291,
1113-1118[CrossRef][Medline]
[Order article via Infotrieve]
10.
Ramakrishnan, B.,
and Qasba, P. K.
(2001)
J. Mol. Biol.
310,
205-218[CrossRef][Medline]
[Order article via Infotrieve]
11.
Boeggeman, E. E.,
Balaji, P. V.,
Sethi, N.,
Masibay, A. S.,
and Qasba, P. K.
(1993)
Protein Eng.
6,
779-785 12.
Zhang, Y.,
Malinovskii, V. A.,
Fiedler, T. J.,
and Brew, K.
(1999)
Glycobiology
9,
815-822 13.
Otwinowski, Z.,
and Minor, W.
(1997)
Methods Enzymol.
276,
307-326
14.
Navaza, J.
(1994)
Acta Crystallogr. Sect. A
50,
760-763
15.
Brunger, A. T.,
et al..
(1998)
Acta Crystallogr. Sect. D Biol. Crystallogr.
54,
905-921[CrossRef][Medline]
[Order article via Infotrieve]
16.
Karulis, P. J.
(1991)
J. Appl. Crystallogr.
24,
946-950[CrossRef]
17.
Ramakrishnan, B.,
Balaji, P. V.,
and Qasba, P. K.
(2002)
J. Mol. Biol.
318,
491-502[CrossRef][Medline]
[Order article via Infotrieve]
18.
Rao, V. S. R.,
Qasba, P. K.,
Balaji, P. V.,
and Chandrasekaran, R.
(1998)
Conformation of Carbohydrates
, Harwood Academic Publishers, Amsterdam, Netherlands
19.
Kim, S. C.,
Singh, A. N.,
and Raushel, F. M.
(1988)
Arch. Biochem. Biophys.
267,
54-59[CrossRef][Medline]
[Order article via Infotrieve]
20.
Hindsgaul, O.,
Kaur, K.,
Srivastava, G.,
Blaszczyk-Thurin, M.,
Crawley, S. C.,
Heerze, L. D.,
and Palcic, M. M.
(1991)
J. Biol. Chem.
266,
17858-17862 21.
Chung, S. J.,
Takayama, S.,
and Wong, C. H.
(1998)
Bioorg. Med. Chem. Lett.
8,
3359-3364[CrossRef][Medline]
[Order article via Infotrieve]
22.
Aoki, D.,
Appert, H. E.,
Johnson, D.,
Wong, S. S.,
and Fukuda, M. N.
(1990)
EMBO J.
9,
3171-3178[Medline]
[Order article via Infotrieve]
23.
Van den Nieuwenhof, I. M.,
Schiphorst, W. E.,
Van Die, I.,
and Van den Eijnden, D. H.
(1999)
Glycobiology
9,
115-123 24.
Lo, N. W.,
Shaper, J. H.,
Pevsner, J.,
and Shaper, N. L.
(1998)
Glycobiology
8,
517-526 25.
Nomura, T.,
Takizawa, M.,
Aoki, J.,
Arai, H.,
Inoue, K.,
Waskisaka, E.,
Yoshizuka, N.,
Imokawa, G.,
Dohmae, N.,
Takio, K.,
Hattori, M.,
and Matsuo, N.
(1998)
J. Biol. Chem.
273,
13570-13577 26.
Van den Nieuwenhof, I. M.,
Schiphorst, W. E.,
and Van den Eijnden, D. H.
(1999)
FEBS Lett.
459,
377-380[CrossRef][Medline]
[Order article via Infotrieve]
27.
Van den Nieuwenhof, I. M.,
Koistinen, H.,
Easton, R. L.,
Koistinen, R.,
Kamarainen, M.,
Morris, H. R.,
Van Die, I.,
Seppala, M.,
Dell, A.,
and Van den Eijnden, D. H.
(2000)
Eur. J. Biochem.
267,
4753-4762[Medline]
[Order article via Infotrieve]
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. Persson, J. A. Letts, B. Hosseini-Maaf, S. N. Borisova, M. M. Palcic, S. V. Evans, and M. L. Olsson Structural Effects of Naturally Occurring Human Blood Group B Galactosyltransferase Mutations Adjacent to the DXD Motif J. Biol. Chem., March 30, 2007; 282(13): 9564 - 9570. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Boregowda, Y. Mi, H. Bu, and J. U. Baenziger Differential expression and enzymatic properties of GalNAc-4-sulfotransferase-1 and GalNAc-4-sulfotransferase-2 Glycobiology, December 1, 2005; 15(12): 1349 - 1358. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Haines and K. D. Irvine Functional analysis of Drosophila {beta}1,4-N-acetlygalactosaminyltransferases Glycobiology, April 1, 2005; 15(4): 335 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Khidekel, S. B. Ficarro, E. C. Peters, and L. C. Hsieh-Wilson Exploring the O-GlcNAc proteome: Direct identification of O-GlcNAc-modified proteins from the brain PNAS, September 7, 2004; 101(36): 13132 - 13137. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sato, M. Gotoh, K. Kiyohara, A. Kameyama, T. Kubota, N. Kikuchi, Y. Ishizuka, H. Iwasaki, A. Togayachi, T. Kudo, et al. Molecular Cloning and Characterization of a Novel Human {beta}1,4-N-Acetylgalactosaminyltransferase, {beta}4GalNAc-T3, Responsible for the Synthesis of N,N'-Diacetyllactosediamine, GalNAc{beta}1-4GlcNAc J. Biol. Chem., November 28, 2003; 278(48): 47534 - 47544. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Marcus, R. Polakowski, N. O. L. Seto, E. Leinala, S. Borisova, A. Blancher, F. Roubinet, S. V. Evans, and M. M. Palcic A Single Point Mutation Reverses the Donor Specificity of Human Blood Group B-synthesizing Galactosyltransferase J. Biol. Chem., March 28, 2003; 278(14): 12403 - 12405. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sato, M. Gotoh, K. Kiyohara, T. Akashima, H. Iwasaki, A. Kameyama, H. Mochizuki, T. Yada, N. Inaba, A. Togayachi, et al. Differential Roles of Two N-Acetylgalactosaminyltransferases, CSGalNAcT-1, and a Novel Enzyme, CSGalNAcT-2. INITIATION AND ELONGATION IN SYNTHESIS OF CHONDROITIN SULFATE J. Biol. Chem., January 24, 2003; 278(5): 3063 - 3071. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. S. Kawar, I. Van Die, and R. D. Cummings Molecular Cloning and Enzymatic Characterization of a UDP-GalNAc:GlcNAcbeta -R beta 1,4-N-Acetylgalactosaminyltransferase from Caenorhabditis elegans J. Biol. Chem., September 13, 2002; 277(38): 34924 - 34932. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||